CStone Pharmaceuticals Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	753.7	387.94	996.67	558.68	742.72
Short-Term Investments	208.79	331.95	51.85	588.91	913.07
Trading Asset Securities	-	-	-	-	122.9
Cash & Short-Term Investments	962.49	719.88	1,049	1,148	1,779
Cash Growth	33.70%	-31.34%	-8.63%	-35.48%	-50.20%
Accounts Receivable	33.81	83.93	172.44	77.13	117.6
Receivables	33.81	83.93	172.44	77.13	117.6
Inventory	116.89	286.1	108.83	22.19	61.36
Total Current Assets	1,113	1,090	1,330	1,247	1,958
Property, Plant & Equipment	83.13	130.54	153.37	206.57	182.8
Long-Term Investments	4.76	9.03	3.54	3.48	3.19
Other Intangible Assets	149.69	161.37	173.05	159.7	70.54
Other Long-Term Assets	7.61	2.62	2.26	21.76	57.28
Total Assets	1,358	1,393	1,662	1,638	2,271
Accounts Payable	306.08	338.03	246.38	290.41	414.29
Accrued Expenses	-	195.23	372.28	400.87	400.65
Current Portion of Long-Term Debt	185.9	60.8	105.99	8.57	30.7
Current Portion of Leases	5.69	32.42	33.33	36.35	13.25
Current Income Taxes Payable	-	1.77	17.66	5.82	24.29
Current Unearned Revenue	10.39	10.39	6.89	7	7.45
Other Current Liabilities	2.17	43.37	67.82	197.46	42.31
Total Current Liabilities	510.22	682.01	850.34	946.48	932.95
Long-Term Debt	156.5	257.4	213	218.99	115.81
Long-Term Leases	0.43	5.36	11.14	22.39	14.44
Long-Term Unearned Revenue	74.45	84.83	61.97	1.25	1.25
Other Long-Term Liabilities	-	-	68.73	-	-
Total Liabilities	741.6	1,030	1,205	1,189	1,064
Common Stock	1	0.86	0.86	0.8	0.8
Additional Paid-In Capital	-	9,004	8,992	8,628	8,465
Retained Earnings	-	-9,111	-9,020	-8,652	-7,750
Treasury Stock	-0	-0.01	-0.01	-0	-0.01
Comprehensive Income & Other	615.77	469.99	483.25	473.09	491.44
Total Common Equity	616.77	363.87	456.83	449.33	1,207
Shareholders' Equity	616.77	363.87	456.83	449.33	1,207
Total Liabilities & Equity	1,358	1,393	1,662	1,638	2,271
Total Debt	348.52	355.97	363.45	286.29	174.2
Net Cash (Debt)	613.97	363.91	685.07	861.31	1,604
Net Cash Growth	68.72%	-46.88%	-20.46%	-46.32%	-54.00%
Net Cash Per Share	0.44	0.29	0.54	0.73	1.38
Filing Date Shares Outstanding	1,505	1,277	1,275	1,198	1,173
Total Common Shares Outstanding	1,505	1,277	1,275	1,198	1,173
Working Capital	602.97	407.9	479.45	300.44	1,025
Book Value Per Share	0.41	0.28	0.36	0.38	1.03
Tangible Book Value	467.08	202.51	283.79	289.63	1,136
Tangible Book Value Per Share	0.31	0.16	0.22	0.24	0.97
Machinery	-	13.79	14.11	19.1	18.95
Construction In Progress	-	151.75	151.75	151.76	138.67
Leasehold Improvements	-	21.28	21.28	21.28	20.31

Source: S&P Global Market Intelligence. Standard template. Financial Sources.